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ABSTRACT
Objectives: The objective of this study is to analyze the effectiveness of Streptococcus salivarius and its protein for inhibiting the growth of Candida 
albicans.
Methods: The analysis was conducted using polymerase chain reaction, sodium dodecyl sulfate polyacrylamide gel electrophoresis, a Bradford test, 
deferred antagonism test, and well-diffusion agar.
Result: S. salivarius, isolated from saliva and the tongue dorsum, and its protein do not inhibit the growth of C. albicans. The morphology of C. albicans 
did not change after being exposed to protein produced by S. salivarius.
Conclusions: S. salivarius and its protein do not inhibit the growth of C. albicans. However, the bacterium has the capacity to maintain fungus 
morphology in the form of blastospora.
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INTRODUCTION
Oral health problems are common in Indonesia and have become 
more complex, resulting in the need for a variety of treatments. Such 
treatments can be conventional, such as using antibiotics, but overuse 
of antibiotic can lead to antibiotic resistance, which is a global health 
concern, both clinically and publically [1]. Therefore, probiotic agents 
have been developed as natural alternatives to oral health treatments. 
According to the World Health Organization, a probiotic is a living 
microorganism that is useful for maintaining health [2]. Probiotics kill 
or inhibit pathogenic bacterial growth by producing bacteriocins or 
other products that act antagonically on pathogenic bacteria. One such 
probiotic is Streptococcus salivarius [3]. S. salivarius originates in the 
womb, is obtained from an infant’s mother several hours after birth, and 
can be identified 2 days after birth [2]. This bacteria is usually isolated 
from saliva and almost all surfaces of the oral cavity, especially the 
tongue and mucus. Known strains include K12, M18, K58, and TOVE-R. 
K12 S. salivarius can bond with Candida albicans hyphae to prevent the 
bacteria from adhering to plastic substrate [4]. This strain has been used 
in New Zealand as an oral isolate probiotic to obstruct in vitro growth of 
C. albicans and has been shown to have the protective ability in an oral 
candidiasis model [5].
Oral candidiasis is an opportunistic and common fungal infection caused 
by C. albicans [6]. C. albicans is a component of normal microflora in the 
oral cavities of 30-50% of humans and is a dimorphic fungi, meaning it 
has two morphologies: A yeast type and a mold type (hyphae) [5]. Oral 
candidiasis caused by C. albicans can be treated by applying antifungal 
agents, such as nystatin and fluconazole [6]; however, there is a chance 
that probiotic agents can also decrease the growth of C. albicans. Protein 
secreted by S. salivarius is a possible natural alternative to antibiotics. 
Even though the probiotic effects of S. salivarius are known, no research 
has been conducted to identify the protein secreted by S. salivarius or 
inhibitory potential for C. albicans growth. Therefore, this research 
analyzes S. salivarius and its protein, isolated from the saliva and tongue 
dorsum of healthy adult subjects, to determine the inhibitory potential for 
C. albicans growth.
METHODS
Samples were swabbed from the dorsum of the tongue and saliva of 10 
healthy adult subjects between 19 and 21 years of age [7]. A centrifuge 
tube (15 ml, 50 ml), cytobrush, 1000 ml tipped pipet, 200 ml tipped 
pipet, micropipette, Eppendorf tube, sterilized reaction tubes, 96-
well microplate, incubator, anaerobic jar, vortex, mini centrifuge, 
autoclave, centrifuge, orbital shaker, enzyme-linked immunosorbent 
assay plater reader, analytic scale, water bath, round end ose berujung 
bulat, light lamp, Petri dishes, thermal cycler T100, electrophoresis, 
Gel Doc, Thermoblock, sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) chamber, SDS-PAGE tank, and AxioCam 
ERc5s (Zeiss) microscope were the tools used to conduct this study. 
Additional materials included a brain-heart infusion (BHI) broth, BHI 
agar, sabouraud dextrose agar, bakto agar (Biomatic), mitis salivarius 
agar (MSA), sterilized aquadest, aquabides, cotton, aluminum foil, 
70% alcohol, gas mixture (N2, CO2: 10%; H2: 10%), phosphate buffer 
saline, primer Sal-AUS (5’-GTAGAAAATATTTACTACATACT) [8], primer 
Sal-ADS (5’-GTTAAAGTATTCGTAAAACTGATG) [8], nucleus-free water, 
Dream Taq, Agarose, gel red, Tris-acetate-ethylenediaminetetraacetic 
acid buffer, 100 bp ladder, 10 mM Tris-HCl pH 7.4 liquid, 0.1 M Tris-
HCL pH 6.8 liquid, phenyl methyl sulfonyl fluoride, glycerol, Coomassie 
brilliant blue, albumin protein standard, acrylamide 40%, stacking 
gel buffer, resolving gel buffer, SDS 10%, ammonium persulfate, 
tetra methyl ethylene diamine, marker protein (Peqlab), MiliQ water, 
Laemmli buffer, β-mercaptoethanol, SDS running buffer, C. albicans 
ATCC 10231 glycerol stocks, and S. salivarius ATCC 13419 glycerol 
stocks.
Subjects were chosen using a non-probability, judgement or purposive 
sampling method, meaning that the researcher chose participants 
based on subjective assessments [9]. Samples of 10 ml were taken from 
stimulated saliva using parafilm M and from the dorsum of subjects’ 
tongues using a cytobrush from the circumvallate papillae to the end 
of the tongue [10]. The samples were cultured in an MSA medium, and 
selective media for Streptococci were used to colonize S. salivarius 
strain of Barbour and Philip and Santagati et al. [11,12].
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Morphology was identified by observing the size and surface consistency 
(i.e., soft or smooth) of colonies, which were confirmed as S. salivarius 
using the polymerase chain reaction (PCR) technique [13]. The 
presence of 118 base-couple DNA bands indicated that colonies were 
S. salivarius. These colonies were bred in a Mueller-Hinton infusion agar 
medium and BHI liquid for 18 hrs. The results were centrifuged, and 
pellets were made from the material separated from the spent medium 
protein using a cell lysate buffer and centrifugation. These were 
analyzed using SDS-PAGE (150 V; 80 mA for 60 minutes) [14]. Proteins 
with the same molecular mass were counted using a Bradford test [15]. 
S. salivarius inhibitory potential against C. albicans was tested using a 
deferred antagonism test [3], and secreted proteins were tested using 
the well-diffused agar method. This method used whole-cell and spent 
medium protein from clinically obtained S. salivarius and S. salivarius 
ATCC 13419 [16]. 
Independent variables were healthy adult saliva and dorsum tongue 
swabs. Dependent variables were S. salivarius inhibitory potential 
against C. albicans 10231, protein secreted by S. salivarius, and 
C. albicans morphological changes. The controlled variable was S. 
salivarius ATCC 13419. Data were analyzed by comparing S. salivarius 
colonies identified in isolated saliva and dorsum tongue swabs to 
colonies that did not contain S. salivarius from the same sources. 
Data were tested using a Fisher’s test, and the means of S. salivarius 
inhibitory proteins for C. albicans growth in each isolated source were 
compared.
RESULTS
Colonies were identified by comparing the morphology of S. salivarius 
cultured from subject samples to the morphology of S. salivarius ATCC 
13419 grown on an MSA medium. From six saliva and tongue dorsum 
samples, similar morphologies to S. salivarius ATCC were obtained 
(Table 1), and a PCR test was conducted to confirm this morphology. 
S. salivarius interaction with C. albicans was tested using the cross-
streak method ( Fig. 1) and a deferred antagonism test. Results for the 
inhibition zone diameter produced by S. salivarius against C. albicans 
were taken in millimeters (mm). From four subjects, only one subject’s 
results could be interpreted; therefore, only saliva and tongue dorsum 
samples from this one subject were used.
Table 2 shows that in all isolated S. salivarius concentrations and 
the S. salivarius ATCC 13419 control, the inhibition zone mean was 0 
mm. Protein secreted by S. salivarius had either whole-cell or spent 
medium protein inhibition potential against C. albicans, which was 
tested using the well-diffused agar method. Table 3 shows that the 
mean inhibition zone of S. salivarius concentrations from isolated 
sources was 0 mm.
Table 4 shows that the inhibition zone around each well of protein 
concentrate isolated from either source was 0 mm. C. albicans was taken 
using the well-diffused agar method and observed microscopically 
to obtain morphological images. Table 5 shows that C. albicans 
morphologic images without protein exhibited germ tube changes, 
while C. albicans exposed to the protein remained blastospores.
Table 1: S. salivarius isolate identifications
Isolated sources S. salivarius colonies
+ (%) – (%)
Saliva 6 (60) 4 (40)
Tongue dorsum 6 (60) 4 (40)
S. salivarius: Streptococcus salivarius
Table 2: The mean for the inhibition zone of each isolate concentration based on a deferred antagonism test
Groups Culture results
S. salivarius ATCC 13419 (CFU/ml) concentration 1.7×1010 1.7×109 1.7×108 1.7×107
S. salivarius ATCC 13419
Inhibition zone mean 0 mm 0 mm 0 mm 0 mm
Clinical S. salivarius (saliva; CFU/ml) concentration 1.9×1010 1.9×109 1.9×108 1.9×107
Clinical S. salivarius (saliva)
Inhibition zone mean 0 mm 0 mm 0 mm 0 mm
Clinical S. salivarius (tongue dorsum) 
concentration (CFU/ml)
1.4×1010 1.4×109 1.4×108 1.4×107
Clinical S. salivarius (tongue dorsum)
Inhibition zone mean 0 mm 0 mm 0 mm 0 mm
S. salivarius: Streptococcus salivarius 
Fig. 1: Polymerase chain reaction results for Streptococcus 
salivarius isolated from the saliva and tongue dorsum. Sal: Saliva 
isolated; L: Tongue dorsum isolated; ATCC: S. salivarius ATCC 
13419
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DISCUSSION
This research identified S. salivarius using cultured samples in an MSA 
medium using PCR tests. Results showed that from 10 samples, six 
subjects (p>0.05) were S. salivarius positive in both saliva and tongue 
dorsum samples. These results are consistent with the results of Ogawa 
et al. (2010) [22] and Wescombe et al. who stated that S. salivarius is 
a pioneer bacteria in the oral cavity and has predominant bacterial 
lifespan [4,16]. Although there was no significant statistical difference, 
low concentrations of S. salivarius found in this research were caused 
by certain factors. The absence of S. salivarius in four subjects was 
due to these subjects’ diets. Ogawa et al. (2010) stated that diet can 
cause a specific microbiota composition due to the intrinsic capacity 
of each person to use consumed substrate. For example, consuming 
polysaccharides causes different microbiota compositions. S. salivarius 
requires energy from sucrose to grow and colonize [16]; thus, another 
study found that sucrose influenced S. salivarius prevalence in adults. 
When sucrose is eliminated from the diet, concentrations of S. salivarius 
in saliva drastically decrease [17].
In addition, Roger et al. [17] stated that enzymes in saliva can 
influence S. salivarius growth in the oral cavity. These enzymes, 
including lysozyme, lactoperoxidase, and amylase, have antibacterial 
activities [17] that can reduce S. salivarius growth. In this research, 
subjects were allowed to eat before sampling, which was performed 
3 hrs after a meal. Subjects also brushed their teeth beforehand; 
therefore, diet differences, enzymes contained in saliva, and samples-
taking procedures all affected the results obtained in this study. 
Table 3: The mean inhibition zone for concentrations of whole‑cell isolate using the well‑diffused agar method
Groups Culture results based on protein concentration
Protein S. salivarius ATCC 13419 concentrations (µg/ml) 146.2 14.62 1.46 1.46×10−1
S. salivarius ATCC 13419
Inhibition zone mean (mm) 0 0 0 0
S. salivarius protein concentrations (saliva; µg/ml) 157.8 15.78 1.578 1.57×10−1
Clinical S. salivarius (saliva)
Inhibition zone mean (mm) 0 0 0 0
Clinical S. salivarius protein concentration (tongue dorsum; µg/ml) 264.4 26.4 2.64 2.64×10−1
Clinical S. salivarius (tongue dorsum)
Inhibition zone mean (mm) 0 0 0 0
S. salivarius: Streptococcus salivarius
Table 4: The mean inhibition zone for protein concentrations in a spent medium isolate using the well‑diffused agar method
Groups Culture results based on protein concentration
Protein S. salivarius ATCC 13419 concentrations (µg/ml) 181.2 18.1 1.81 1.81×10−1
S. salivarius ATCC 13419
Inhibition zone mean (mm) 0 0 0 0
Clinical S. salivarius protein concentrations (saliva; µg/ml) 178.3 17.83 1.78 1.78×10−1
Clinical S. salivarius (saliva)
Inhibition zone mean (mm) 0 0 0 0
Clinical S. salivarius protein concentrations (tongue dorsum; µg/ml) 167.9 16.79 1.68 1.68×10−1
Clinical S. salivarius (tongue dorsum)
Inhibition zone mean (mm) 0 0 0 0
S. salivarius: Streptococcus salivarius
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The specific protein secreted by S. salivarius colonies was identified 
using an SDS-PAGE test. Protein used in this test was presented as 
whole-cell protein (i.e., protein inside cellular membranes) and spent 
medium (i.e., protein secreted outside the cell). Barbour and Philip 
(2014) stated that 60-70% of bacteriocin are peptides that bond 
with bacterial cell-producer walls, while other inhibitory peptides 
are secreted extracellular in liquid mediums. Secreted peptides are 
dominant in antibiotic production because they act as communication 
molecules that accumulate during the growth process. In some 
concentrations, lantibiotic production is triggered [11]. According 
to Wescombe et al. [8], salivaricin A production can be detected in 
individuals’ saliva in varying concentrations because there is a variety 
of salivary flow rates that dissolve salivaricin A and allow adsorption in 
normal cell flora [8]. SDS-PAGE results in the current study showed that 
from six S. salivarius samples, only four subjects produced protein with 
the same profiles, containing one band located inline. The absence of 
spent medium protein could be due to the communication mechanism 
not triggering protein production. An S. salivarius inhibition potential 
analysis was conducted to isolate it from the saliva and tongue dorsum 
samples from one subject, as well as S. salivarius ATCC 13419 and 
C. albicans, using the deferred antagonism test method and cross streak 
test. The results revealed that C. albicans growth was not inhibited 
by S. salivarius ATCC 13419 concentrations from either saliva or the 
tongue dorsum. 
According to Morales and Hogan [18], bacteria and fungi have 
structural shapes, and the surfaces can interact to form communities 
known as biofilms. The interaction between C. albicans and oral 
Streptococci aggregates on cellular surfaces and forms a mixed-species 
biofilm [18]. According to Shirtliff et al. [19], the interaction between 
C. albicans and Streptococci gives synergistic results, in that Streptococci 
produces lactacyd acid that acts as a carbon source for Candida growth. 
In turn, C. albicans reduces oxygen pressure to a more suitable level 
for Streptococci, which stimulates bacterial growth due to nutritional 
metabolic support [19,20].
To analyze S. salivarius microbial activity further, inhibition potential 
tests were conducted on the protein secreted by S. salivarius against 
C. albicans using the well-diffusion agar method. S. salivarius produces 
bacteriocin, primarily lantibiotic, in the form of salivaricin [4]. The cell 
lysate method was used to obtain whole-cell protein, and spent medium 
protein was obtained by centrifugation. Similar to earlier results, 
protein inhibition potential tests showed that there was no C. albicans 
growth inhibition from either saliva-isolated or tongue-dorsum-
isolated protein or ATCC 13419 concentrations of either whole-cell or 
spent medium proteins. Ishijima et al. [5] found that S. salivarius K12 is 
effective against in vitro-cultured C. albicans growth because S. salivarius 
K12 bonded directly to Candida, inhibiting adhesion to a plastic Petri 
dish. S. salivarius K12 bonded to Candida during germ tube formation, 
and no Candida hyphae form was found [5]. In the current research, 
microscopic images were obtained to identify C. albicans morphology, 
which showed that controlled C. albicans entered the germ tube stage, 
while C. albicans exposed to either whole-cell or spent medium protein 
remained in the blastospore stage. This finding was supported by 
Ishijima et al. [5], who found that S. salivarius K12 reduced C. albicans’ 
ability to maintain its blastospore shape. Thus, S. salivarius does not 
kill C. albicans but interacts and bonds with C. albicans hyphae and 
cannot inhibit C. albicans growth based on a deferred antagonism test, 
which showed that bacteriocin coded from the K12 strain did not target 
yeast [4,5]. MacDonald showed that S. salivarius K12 and M18 strains do 
not reduce yeast growth but inhibit hyphae formation and adhesion to 
surfaces of yeast [21]. Spent medium protein from S. salivarius K12 and 
M18 strains also significantly reduced C. albicans adhesion to wells and 
inhibit transition to hyphae form. This is consistent with results from 
Köhler et al. [9], in which lactobacilli probiotic influenced the C. albicans 
metabolism and increased in relation to stress. Similarly, fungi were also 
challenged by Lactobacilli acid production, which reduced pH [9,21].
According to research by Köhler et al. [9], spent medium protein from 
probiotics have lower pH levels than C. albicans in normal growth media; 
thus, reducing pH can also reduce C. albicans adhesion. Stable spent 
medium pH does not reduce adhesion significantly, but decreasing spent 
medium pH decreases C. albicans adhesion. In addition, low pH levels 
support C. albicans yeast growth and inhibit hyphae formation [9,21]. 
In this research, protein secreted by S. salivarius was determined 
to have the potential to inhibit C. albicans morphological changes by 
maintaining the blastospore form, presumably due to low pH levels and 
related stress increases that influence C. albicans metabolic activity.
CONCLUSION
This research showed that S. salivarius, obtained from saliva or 
tongue dorsum samples, does not have a potential inhibitory effect 
on C. albicans growth. Either S. salivarius whole-cell or spent medium 
protein secreted from saliva or the tongue dorsum does have the 
potential to inhibit C. albicans morphological changes from blastospore 
to hyphae. It is suggested that purifying lantibiotic secreted by 
S. salivarius or using an auto-induction method could be used to obtain 
specific lantibiotic types. The K12 S. salivarius strain could be positively 
controlled in the future research, and further analysis of lantibiotic 
as a probiotic to prevent and treat oral candidiasis is necessary. The 
therapeutic effects of lantibiotic against C. albicans could be determined 
by conducting a candidiasis oral analysis.
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